Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Alector stock in Canada | $36.91

Own Alector shares in just a few minutes.

Alector, Inc
NASDAQ: ALEC - USD
BIOTECHNOLOGY
$25.79
+$0.45 (+1.78%)

Alector (ALEC) is a leading biotechnology business based in the US. It opened the day at $39.6 after a previous close of $39.13. During the day the price has varied from a low of $35.57 to a high of $39.74. The latest price was $36.91 (25 minute delay). Alector is listed on the NASDAQ and employs 181 staff. All prices are listed in US Dollars.

How to buy Alector stock in Canada

  1. Choose a platform. If you're a beginner, our stock trading table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: ALEC in this case.
  5. Research Alector stocks. The platform should provide the latest information available.
  6. Buy your Alector stocks. It's that simple.

How has Coronavirus impacted Alector's stock price?

Since the stock market crash in March caused by coronavirus, Alector's stock price has had significant negative movement.

Its last market close was $17.8, which is 41.58% down on its pre-crash value of $30.47 and 16.01% down on the lowest point reached during the March crash when the stocks fell as low as $20.65.

If you had bought $1,000 worth of Alector stocks at the start of February 2020, those stocks would have been worth $844.54 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $631.37.

Alector stock price

Use our graph to track the performance of ALEC stocks over time.

Alector stocks at a glance

Information last updated 2021-07-09.
Open$39.6
High$39.74
Low$35.57
Close$36.91
Previous close$39.13
Change $-2.22
Change % -5.6734%
Volume 1,414,530
Information last updated 2021-07-28.
52-week range$9.12 - $39.74
50-day moving average $27.524
200-day moving average $20.5391
Wall St. target price$38.75
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.255

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Available Asset Types Stock Fee Option Fee Account Fee ETF Transaction Cost Feature Table description
OFFER
Wealthsimple Trade
Stocks, ETFs
$0
N/A
$0
Free
Get a $50 bonus when you open a Wealthsimple Trade account and deposit and trade at least $100.
Pay no commissions when you trade Canadian stocks and ETFs with Wealthsimple Trade.
Scotia iTRADE
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
$4.99-$9.99
$9.99 + $1.25 contract ($4.99 + $1.25 contract if completed 150 trades or more a quarter)
$0
$9.99 ($4.99 if completed 150 trades or more a quarter)
Pay no annual account fees.
Buy, sell and trade ETFs, Equities, Options and more with competitive commissions.
CIBC Investor's Edge
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95 - $6.95
$4.95 - $6.95 (+$1.25 per contract)
$0 if conditions met, otherwise $100/year
$6.95
$4.95 - $6.95 is applicable for online stock, ETF and option trades only. Pay $4.95 when you qualify as an Active Trader (trade 150+ times per quarter).
An intuitive and easy-to-use platform with access to a variety of tools that help you make smart decisions and trade with confidence.
Interactive Brokers
Stocks, Bonds, Options, ETFs, Currencies, Futures
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
$0
Min. $1.00, Max. 0.5% of trade value
Extensive trading capabilities and global investment tracking.
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
Questrade
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95-$9.95
$9.95 + $1 per contract
$0
Free
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
OFFER
Qtrade Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$6.95 - $8.75 + $1.25 per contract
$0 if conditions met, otherwise $25/quarter
$0 - $8.75
Get up to 50 free trades. Be one of the first 100 new Qtrade clients to use the promo code 50FREETRADES and deposit a minimum of $10,000 (or top up to $15,000 to get $150 transfer fees waived). Valid until September 30, 2021.
Qtrade Direct Investing offers low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options. Trade 100 ETFs free of charge and thousands more for $8.75 or lower.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Alector stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Alector price performance over time

Historical closes compared with the last close of $36.91

1 month (2021-07-02) 4.83%
3 months (2021-05-03) 95.50%

Alector financials

Revenue TTM USD$18 million
Gross profit TTM USD$-135,771,000
Return on assets TTM -24.25%
Return on equity TTM -65.33%
Profit margin 0%
Book value $2.857
Market capitalisation USD$2.4 billion

TTM: trailing 12 months

How to short and sell Alector stocks

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "ALEC.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 6.2 million Alector stocks held short by investors – that's known as Alector's "short interest". This figure is 16.6% down from 7.4 million last month.

There are a few different ways that this level of interest in shorting Alector stocks can be evaluated.

Alector's "short interest ratio" (SIR)

Alector's "short interest ratio" (SIR) is the quantity of Alector stocks currently shorted divided by the average quantity of Alector stocks traded daily (recently around 3.0 million). Alector's SIR currently stands at 2.09. In other words for every 100,000 Alector stocks traded daily on the market, roughly 2090 stocks are currently held short.

However Alector's short interest can also be evaluated against the total number of Alector stocks, or, against the total number of tradable Alector stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Alector's short interest could be expressed as 0.08% of the outstanding stocks (for every 100,000 Alector stocks in existence, roughly 80 stocks are currently held short) or 0.1194% of the tradable stocks (for every 100,000 tradable Alector stocks, roughly 119 stocks are currently held short).

Such a low SIR usually points to an optimistic outlook for the stock price, with fewer people currently willing to bet against Alector.

Find out more about how you can short Alector stock.

Alector stock dividends

We're not expecting Alector to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.

Alector stock price volatility

Over the last 12 months, Alector's stocks have ranged in value from as little as $9.12 up to $39.74. A popular way to gauge a stock's volatility is its "beta".

ALEC.US volatility(beta: 1.04)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Alector's is 1.0437. This would suggest that Alector's stocks are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Alector overview

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase Ib clinical trial for the treatment of Alzheimer's disease. In addition, its products in development stage include AL044 that targets MS4A4A, a risk gene for Alzheimer's disease; and 8 candidates in immuno-neurology/immuno-oncology field comprise ADP012, ADP016, ADP017, ADP023, ADP026, ADP122, ADP009, and ADP022. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies. The company was founded in 2013 and is headquartered in South San Francisco, California.

Stocks similar to Alector

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site